MDS patients petition new UK government for access to Celgene's Vidaza
This article was originally published in Scrip
Executive Summary
Patient groups yesterday presented the UK's new Prime Minister David Cameron with a petition calling for access to Celgene's anticancer, Vidaza (5-azacitidine) to treat bone marrow diseases. The move comes after English and Scottish health technology appraisal bodies declined to recommend the drug earlier this year.